Mr Greyden Kurosumi, MS in Honolulu, HI - Speech-Language Pathologist

Mr Greyden Kurosumi, MS is a Speech-language Pathologist based in Honolulu, Hawaii. Mr Greyden Kurosumi is licensed to practice in Hawaii (license number SP - 1315) and his current practice location is 3247 Woodlawn Dr, Honolulu, Hawaii. He can be reached at his office (for appointments etc.) via phone at (808) 230-4112.

NPI number for Mr Greyden Kurosumi is 1083049381 and his current mailing address is 3247 Woodlawn Dr, Honolulu, Hawaii. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1083049381.

Contact Information

	Mr Greyden Kurosumi, MS
	3247 Woodlawn Dr, Honolulu, HI 96822-1469
	(808) 230-4112
	Not Available

Healthcare Provider's Profile

Full Name	Mr Greyden Kurosumi
Gender	Male
Speciality	Speech-language Pathologist
Location	3247 Woodlawn Dr, Honolulu, Hawaii
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1083049381
Provider Enumeration Date: 09/05/2013
Last Update Date: 09/05/2013

Medical Identifiers

Medical identifiers for Mr Greyden Kurosumi such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1083049381	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	SP - 1315 (Hawaii)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Greyden Kurosumi is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Greyden Kurosumi, MS 3247 Woodlawn Dr, Honolulu, HI 96822-1469 Ph: (808) 230-4112	Mr Greyden Kurosumi, MS 3247 Woodlawn Dr, Honolulu, HI 96822-1469 Ph: (808) 230-4112

News Archive

Also in Global Health news: Drug trafficking in Kenya; violence in S. Sudan; Uganda bill; sleeping sickness

Drug trafficking and use are fueling the spread of HIV/AIDS in Kenya, according to a recent report by the U.N. Security Council, the Nation reports. "A statement from the council's Presidency currently … states that Afghan heroin was being imported, causing a dramatic increase in heroin addiction and spreading HIV/AIDS in the slums of Nairobi and Mombasa, Kenya's two main cities," the newspaper writes.

Chaperone protein imbalance can play key role in initiating toxic tau buildup in the aging brain

Chaperone protein imbalance can play a significant role in initiating toxic accumulation of tau in the aging brain - an early step in the development of Alzheimer's disease and related neurodegenerative disorders known as tauopathies, a new preclinical study by University of South Florida Health (USF Health) neuroscientists suggests.

New analysis highlights ongoing scale of tobacco problem among children

Every year around 157,000 children aged 11-15 start smoking - that's enough to fill 5,200 classrooms or make up nearly 14,000 junior football teams. These shocking figures, revealed in a new analysis by Cancer Research UK, highlight the ongoing scale of the tobacco problem, and underline the importance of sustained action to discourage young people from starting to smoke, including by introducing plain packaging for all tobacco products as soon as possible.

Study proposes new approach that cures multidrug-resistant TB in conflict-affected communities

A high proportion of multidrug-resistant tuberculosis cases can be cured in conflict-affected communities with molecular diagnostics, shorter treatment periods and socioeconomic incentives, according to the results of a large, long-term study in the Democratic Republic of Congo led by the University of Pittsburgh Graduate School of Public Health and Stellenbosch University in South Africa, in collaboration with the DRC National Tuberculosis Program.

Preliminary analysis of photon therapy treatment group 1 shows no significant differences between arms

A preliminary analysis of photon therapy treatment group 1 from the phase II NRG Oncology clinical trial NRG-BN001 indicates that there is no statistically significant overall survival (OS) or toxicity differences between dose-intensification radiation therapy (DI-RT) using intensity-modulated radiation therapy (IMRT) and standard-dose radiation therapy (SD-RT) with temozolomide treatments for patients with newly diagnosed glioblastoma (GBM).

Speech-Language Pathologist in Honolulu, HI

Lauren Marie Eudoxie, M.SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 725 Kapiolani Blvd, Honolulu, HI 96813 Phone: 808-596-4650
Jacquelyn Jarachovic, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1519 Queen Emma St, Honolulu, HI 96813 Phone: 808-587-4510
Shauna Ainuu, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 710 Green St, Honolulu, HI 96813 Phone: 808-536-3764
Maria Jordan, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 475 22nd Ave Rm 127, Honolulu, HI 96816 Phone: 808-733-4940
Tina Thanh Huong Le, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 475 22nd Ave # 302, Honolulu, HI 96816 Phone: 808-305-9750 Fax: 808-733-9154
Marissa Lyn Cheape, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 475 22nd Ave Rm 127, Honolulu, HI 96816 Phone: 808-627-7300
Mrs. Christie Eiko Hoota Iraha, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 475 22nd Ave Rm 127, Honolulu, HI 96816 Phone: 808-282-2333

Mr Greyden Kurosumi, MS - Speech-Language Pathologist in Honolulu, HI